(−)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 77, 100-119
Abstract
No abstract availableKeywords
Funding Information
- Kuwait University (MA01/08)
This publication has 91 references indexed in Scilit:
- Inflammation and axon regenerationCurrent Opinion in Neurology, 2011
- Alteration of Glial Fibrillary Acidic Proteins Immunoreactivity in Astrocytes of the Spinal Cord Diabetic RatsThe Anatomical Record, 2008
- Delayed Transplantation with Exogenous Neurotrophin Administration Enhances Plasticity of Corticofugal Projections after Spinal Cord InjuryJournal of Neurotrauma, 2007
- Green Tea Epigallocatechin-3-Gallate Mediates T Cellular NF-κB Inhibition and Exerts Neuroprotection in Autoimmune EncephalomyelitisThe Journal of Immunology, 2004
- Nestin expression in hippocampal astrocytes after injury depends on the age of the hippocampusGlia, 2004
- Epigallocatechin, a Green Tea Polyphenol, Attenuates Myocardial Ischemia Reperfusion Injury in RatsMolecular Medicine, 2004
- Pegylated Brain-Derived Neurotrophic Factor Shows Improved Distribution into the Spinal Cord and Stimulates Locomotor Activity and Morphological Changes after InjuryExperimental Neurology, 2001
- Pathogenesis and Pharmacological Strategies for Mitigating Secondary Damage in Acute Spinal Cord InjuryNeurosurgery, 1999
- MASCIS Evaluation of Open Field Locomotor Scores: Effects of Experience and Teamwork on ReliabilityJournal of Neurotrauma, 1996
- A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in RatsJournal of Neurotrauma, 1995